Radoslaw Rudz posted this:
Licensing Manager at Centre Technology Transfer CITTRU
Licensing Manager at uacoopera
uacoopera posted this:
Licensing Manager at uacoopera
uacoopera posted this:Electrochemical biosensor for the detection and quantification of alkylphenols.A group of researchers from Portuguese university developed a biosensor for the detection and quantification of alkylphenols (AP). This invention constitutes a fast, efficient and accurate method for the quantification of these contaminants, found in items ranging from detergents and pesticides to plastics, textiles and fuels. The apparatus has already been successfully tested in real samples and demonstrated to be faster and more efficient than the commonly used techniques for the quantification of AF, not requiring additional steps, namely, for sample preparation.
Universidad de Alcalá-OTRI posted this:Carbosilane dendritic compounds homo and heterofunctionalizedA Spanish research group from the Department of Organic and Inorganic Chemistry of Alcala University has developed a highly branched macromolecules called dendrimers or dendrons, with carbosilane structure and functionalized on its periphery with anionic or cationic groups, providing the macromolecule a net negative or positive charge respectively. The invention also concerns the dendrimers’ procurement process and their biomedical applications, particularly as carriers of drugs or nucleic acids (such ODN, siRNA, dsRNA or DNA), or as therapeutic agents with antiviral or antibacterial activity. The group is looking for companies in the biomedical sector to reach licensing agreements, collaboration and commercial agreements with technical assistance.
Universidad de Alcalá-OTRI posted this:New organo-metallic catalysts for the manufacture of polymersA research group from the Inorganic Chemistry Department of Alcalá University has developed a technology that presents a range of catalysts based on coordination complexes and organometallic, active in functionalization processes (expoditation, hydrosilylation) and polymerization of different organic substrates (olefins and cyclic esters). They are metal complexes belonging to the first transition groups (groups 4-6) and elements from the main groups (groups 1,2 and 13). Its application is aimed at the synthesis of materials with new properties (silicon polymers, biodegradable plastics, polyesters) and the production of small molecules with high added value, used as starting products in many industrial processes (epoxides, silanes). The group is looking for manufacturing agreements and joint venture agreements with companies from the agrofood industry, construction and petrochemicals.
Universidad de Alcalá-OTRI posted this:Double mesh prosthesis that corrects defects in the abdominal wall and prevents adhesion formation at the peritoneal interfaceA research group from the Surgery Department of Alcala University has designed an implantable prosthesis made of two meshes joined together, for abdominal surgery uses. This prosthesis prevents the erosion of the viscera by promoting mesothelial deposition. Both meshes induce fibroblast proliferation and collagen deposition achieving the definitive repair of the defect at the expense of connective tissue. This research group is looking for manufacturing and license agreements.
Universidad de Alcalá-OTRI posted this:Protein separation by using anionic carbosilane dendrimers.BIODEN research group (Biomedical applications of dendrimers) from the Department of Inorganic Chemistry of the University of Alcala along with the research group of Micro(sep) from the Department of Analytical Chemistry and Chemical Engineering have developed a technology based on the use of anionic dendrimers as nanoadditives in capillary electrophoresis (CE) for protein separation, more specifically for obtaining protein profiles useful in food characterization. The groups look for companies of chemical, pharmaceutical or biotechnological sector to sign research collaboration agreements or license agreements.
Technology Transfer Office
RAMOT at Tel Aviv University Ltd. posted this:Iron oxide nanoparticles (IOP) for the treatment of acute myocardial infarction (AMI) and other inflammatory conditionsA novel approach for the treatment of AMI has been developed using IOPs. IOPs, when injected into the infarcted myocardium, lead to improved heart function after MI. IOPs activate anti-inflammatory macrophages and thus promote tissue healing and repair and prevent myocardial remodeling and dysfunction. Potential Applications IOPs can be used to treat AMI and other inflammatory conditions associated with pro-inflammatory activated macrophages and to promote tissue healing and repair. Advantages ? IOPs are nontoxic ? IOPs are FDA approved for use in humans for MRI imaging Stage In vivo studies in mouse and rat models of MI and heart failure Project ID : 10-2011-247